新闻中心

News Center

The 4th China (Shenzhen) Mental Health Leaders Summit was successfully held

Release Time

2022-06-22 09:53

      Gather leaders in the field of mental health to discuss the future of the discipline. The 4th China (Shenzhen) Mental Health Leaders Summit, the top event in the field of psychiatry in China exclusively hosted by Shenzhen Foncoo Pharmaceutical Co., Ltd., was held in Shenzhen on December 8, 2018.

      More than 50 well-known experts in the field of mental health in China and more than 260 representatives from mental health institutions in Beijing, Shanghai, Sichuan and other regions gathered together to discuss the development of mental health in China. The experts who participated in the conference spoke the most wanted and important things this year in the fields they were best at. In addition, more than 12,000 leaders and experts who pay attention to and support the development of mental health undertakings watched the summit through live webcast.

 

Summit scene

 

       Academician of Chinese Academy of Sciences, President of Peking University Sixth Hospital, Deputy Secretary General of Shenzhen Municipal Government Wu You, Deputy Director of Shenzhen Public Hospital Management Center Lin Hancheng, and President of Shenzhen Kangning Hospital Liu Tiebang delivered speeches respectively, wishing the meeting a complete success.

 

The summit is divided into three parts: "Academician Voice", "Annual Progress Report" and "Young Leaders Forum".

 

       In the academician voice session, Academician Lu Lin gave a special report on the historical mission of mental health workers in my country. He pointed out that the burden of mental illness in my country is very heavy, and the mental health problems of children and adolescents are more prominent. Experts in the field of mental health should cooperate with experts in other fields to jointly promote the development of mental health.

       In the annual progress report session, the speakers made reports on ten topics, including depressive disorder, bipolar disorder, schizophrenia, substance abuse, rehabilitation, institution building, private institutions, community prevention and treatment, psychotherapy, and physical therapy. Lively discussions around the topic.

 

Speakers make special reports

 


Discussing topics that are hotly debated by guests

 

       During the Young Leaders Forum, representatives of outstanding young experts in the field of mental health from across the country expounded their views on topics such as the training of young doctors and the latest research progress.

 

       At the end of the meeting, Lu Lin, an academician of the Chinese Academy of Sciences, awarded our company the "Academic Support Award for the China Mental Health Leaders Summit", and Ms. Bao Danhua, the marketing director of our company, took the stage to accept the award on behalf of the company.

       The China (Shenzhen) Mental Health Leaders Summit started in 2015, and the summit has played a pivotal role in promoting the development of national mental health. At the same time, it has built a platform for exchanges and cooperation between Shenzhen and national mental health institutions. In 2018, the summit was rated as a high-level medical academic conference in Shenzhen by the Shenzhen Municipal Health and Family Planning Commission.

       The 4th China (Shenzhen) Mental Health Leaders Summit is organized by the Chinese Medical Association Psychiatry Branch, the Chinese Medical Doctor Association Psychiatrist Branch, the Chinese Hospital Association Psychiatric Hospital Management Branch, the Chinese Neuroscience Society Psychiatry Basic and Clinical Branch, and the Chinese Substance Abuse Prevention and Control Branch. Sponsored by the Association and the Editorial Committee of China Psychiatry Magazine, co-organized by Shenzhen Kangning Hospital, the Sixth Hospital of Peking University, the Second Xiangya Hospital of Central South University, and Shanghai Mental Health Center, and exclusively organized by Shenzhen Foncoo Pharmaceutical Co., Ltd.

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称